Citadel Advisors - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$278,176,000
+160.0%
3,271,502
+8.4%
0.08%
+102.6%
Q2 2020$106,986,000
+149.1%
3,018,775
-5.3%
0.04%
+105.3%
Q1 2020$42,950,000
+48.3%
3,186,252
+132.9%
0.02%
+46.2%
Q4 2019$28,954,000
-20.8%
1,368,315
-50.4%
0.01%
-27.8%
Q3 2019$36,567,000
-39.2%
2,757,719
-36.4%
0.02%
-35.7%
Q2 2019$60,134,000
+258.7%
4,335,487
+396.8%
0.03%
+211.1%
Q1 2019$16,764,000
-28.1%
872,652
-46.6%
0.01%
-30.8%
Q4 2018$23,322,000
-33.7%
1,634,349
-3.3%
0.01%
-18.8%
Q3 2018$35,197,000
-35.3%
1,689,778
-26.5%
0.02%
-40.7%
Q2 2018$54,418,000
+68.0%
2,299,010
+3.7%
0.03%
+58.8%
Q1 2018$32,397,000
-60.8%
2,217,497
-56.7%
0.02%
-66.0%
Q4 2017$82,685,000
+255.9%
5,116,684
+207.9%
0.05%
+194.1%
Q3 2017$23,230,000
+755.3%
1,661,707
+440.2%
0.02%
+750.0%
Q2 2017$2,716,000
-26.5%
307,600
-46.2%
0.00%
-50.0%
Q1 2017$3,697,000
+346.5%
571,427
+153.2%
0.00%
Q4 2016$828,000
+13.6%
225,700
+0.6%
0.00%
Q3 2016$729,000
+757.6%
224,427
+560.1%
0.00%
Q1 2016$85,000
-42.2%
34,000
-29.2%
0.00%
Q4 2015$147,000
+206.2%
47,990
+70.2%
0.00%
Q3 2015$48,000
-41.5%
28,195
+31.9%
0.00%
Q1 2015$82,000
-56.8%
21,384
-45.8%
0.00%
Q4 2014$190,000
-4.0%
39,486
-26.1%
0.00%
Q3 2014$198,000
+23.0%
53,437
+21.3%
0.00%
Q2 2014$161,000
-25.5%
44,055
-14.2%
0.00%
Q1 2014$216,000
-81.3%
51,357
-79.6%
0.00%
-100.0%
Q4 2013$1,158,000
-4.8%
251,856
+28.1%
0.00%0.0%
Q3 2013$1,217,000
+27.3%
196,566
+11.9%
0.00%0.0%
Q2 2013$956,000175,6590.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders